Aurora Cannabis Inc Market Cap ($236.15 Million)

$236.15 Million USD  · Rank #15683

Market Cap & Net Worth: Aurora Cannabis Inc (ACB)

Aurora Cannabis Inc market cap. Aurora Cannabis Inc (NASDAQ:ACB) has a market capitalization of $236.15 Million ($236.15 Million) as of November 7, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15683 globally and #3723 in its home market, demonstrating a 27.21% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aurora Cannabis Inc's stock price $5.19 by its total outstanding shares 63310061 (63.31 Million). Also see Aurora Cannabis Inc cash conversion from operations for how efficiently the company converts equity into cash flow.

Aurora Cannabis Inc Market Cap History (2015–2026)

Aurora Cannabis Inc market cap history from 2015 to 2026. Data shows change from $3.15 Billion to $328.58 Million (-15.83% CAGR). Check Aurora Cannabis Inc (ACB) stock price for real-time trading data and today's change.

Index Memberships

Aurora Cannabis Inc is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NASDAQ Health Care
IXHC
$2.59 Trillion 0.01% #418 of 976
NASDAQ Composite
IXIC
$38.55 Trillion 0.00% #1526 of 3165

Weight: Aurora Cannabis Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Aurora Cannabis Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Aurora Cannabis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Aurora Cannabis Inc (ACB) net asset momentum to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

1.02x

Aurora Cannabis Inc's market cap is 1.02 times its annual revenue

Industry average: 0.59x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2017 $57.32 Billion $18.07 Million -$12.97 Million 3172.56x N/A
2018 $37.68 Billion $55.20 Million $71.94 Million 682.70x 523.83x
2019 $16.41 Billion $245.54 Million -$293.51 Million 66.83x N/A
2020 $5.26 Billion $268.70 Million -$3.28 Billion 19.58x N/A
2021 $3.43 Billion $245.25 Million -$693.62 Million 13.97x N/A
2022 $584.10 Million $221.34 Million -$1.74 Billion 2.64x N/A
2023 $301.48 Million $223.80 Million -$816.63 Million 1.35x N/A
2024 $269.07 Million $270.28 Million -$69.33 Million 1.00x N/A
2025 $267.17 Million $343.29 Million $1.59 Million 0.78x 167.92x
2026 $328.58 Million $320.59 Million -$121.76 Million 1.02x N/A

Competitor Companies of ACB by Market Capitalization

Companies near Aurora Cannabis Inc in the global market cap rankings as of November 7, 2026. Also see Aurora Cannabis Inc asset portfolio for a full breakdown of the balance sheet.

Key companies related to Aurora Cannabis Inc by market ranking:

  • Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #506 globally with a market cap of $52.60 Billion USD.
  • GALDERMA GROUP AG (NYSE:GALDY): Ranked #532 globally with a market cap of $50.42 Billion USD.
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #570 globally with a market cap of $46.85 Billion USD ( CN¥320.16 Billion CNY).
  • Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #615 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#506 Takeda Pharmaceutical Co Ltd ADR NYSE:TAK $52.60 Billion $16.65
#532 GALDERMA GROUP AG NYSE:GALDY $50.42 Billion $47.40
#570 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $46.85 Billion CN¥50.19
#615 Takeda Pharmaceutical Company Limited F:TKDA $43.60 Billion €19.30

Market Capitalization of Aurora Cannabis Inc (2015–2026)

Market capitalization of Aurora Cannabis Inc from 2015 to today. Between 2015 and today, Aurora Cannabis Inc's market cap moved from $3.15 Billion to $ 328.58 Million, with a yearly change of -15.83%.

Year Market Cap Change (%)
2026 $328.58 Million +22.99%
2025 $267.17 Million -0.71%
2024 $269.07 Million -10.75%
2023 $301.48 Million -48.38%
2022 $584.10 Million -82.95%
2021 $3.43 Billion -34.90%
2020 $5.26 Billion -67.94%
2019 $16.41 Billion -56.45%
2018 $37.68 Billion -34.26%
2017 $57.32 Billion +343.60%
2016 $12.92 Billion +310.11%
2015 $3.15 Billion --

End of Day Market Cap According to Different Sources

On Nov 6th, 2026 the market cap of Aurora Cannabis Inc was reported to be:

Source Market Cap
Yahoo Finance $236.15 Million USD
MoneyControl $236.15 Million USD
MarketWatch $236.15 Million USD
marketcap.company $236.15 Million USD
Reuters $236.15 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$328.58 Million
Market Cap Rank
#15683 Global
#3723 in USA
Share Price
$5.19
Change (1 day)
-0.95%
52-Week Range
$2.58 - $5.57
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more